BioPharm International, October 2010 Issue (PDF)
Biopharmaceutical Approvals in the US and EU: A Review
Uncertain Outlook for Biopharma Venture Capital
Venture capital is still scarce for early biotechs and their providers.
Regulatory Challenges Impede the Adoption of New Downstream Processing Technologies
Can vendor-user partnerships overcome the typical wait-and-see attitude toward new technologies?
Biopharmacetiucal Approval Trends in 2009
Biotech approvals were up last year. Is it a sign of a new trend?
A Quality Culture Can Be the Industry's Core Strength
How should the industry educate the public about product quality?
Biotech Companies Gain Support for Vaccine, Countermeasure Production
A new strategy to streamline vaccine development and oversight.
Taking on the Challenges
Good leaders look beyond industry woes to focus on patients
Biotech Cools Off as Capital Markets Weaken
Biotech's mid-sized elites position themselves for growth.
The Role of Noncritical Process Parameters in Quality by Design
Industry and regulators disagree over noncritical parameters.
